Document ID: chunk:federal_register_of_legislation:C2018A00007:clause:9_39
Version: federal_register_of_legislation:C2018A00007
Segment Type: clause
Provision Reference: sch 9 cl 39
Character Range: 260937–262734

39  Application provisions—therapeutic goods
(1) Subsection 19(1AA) of the Therapeutic Goods Act 1989, as inserted by this Schedule, applies in relation to approvals granted on or after the commencement of this item.
(2) The amendment of paragraph 19(2)(a) of the Therapeutic Goods Act 1989 made by this Schedule applies in relation to applications made on or after the commencement of this item.
(3) Subsection 19(5AA) of the Therapeutic Goods Act 1989, as inserted by this Schedule, applies in relation to applications made on or after the commencement of this item.
(4) The repeal and substitution of subsection 22(6) of the Therapeutic Goods Act 1989 made by this Schedule applies in relation to claims made on or after the commencement of this item.
(5) Subsection 25AA(1B) of the Therapeutic Goods Act 1989, as inserted by this Schedule, applies in relation to medicine that becomes restricted medicine on or after the commencement of this item, whether the medicine was included in the Register before, on or after that commencement.
(6) The amendment of subsection 28(5) of the Therapeutic Goods Act 1989 made by this Schedule applies in relation to the registration or listing of therapeutic goods before, on or after the commencement of this item.
(7) The Therapeutic Goods Act 1989, as in force immediately before the commencement of this item, continues to apply on and after that commencement in relation to a request referred to in subsection 28(5A) of that Act that was made before that commencement.
(8) The amendment of paragraph 29D(1)(b) of the Therapeutic Goods Act 1989 made by this Schedule applies in relation to suspensions made on or after the commencement of this item (whether the therapeutic goods were included in the Register before, on or after that commencement).